Document Detail


Expression of endothelin 1 in rat random-pattern skin flaps treated with topical nifedipine.
MedLine Citation:
PMID:  12533145     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the relative tissue concentrations of the endogenous vasoactive peptide endothelin 1 (ET-1) in random-pattern skin flaps (RPSF) treated with either topical anti-ischemic drug therapy (nifedipine) or placebo.
DESIGN: Prospective, randomized, placebo-controlled therapeutic trial.
SUBJECTS: Adult male Sprague-Dawley rats.
INTERVENTION: Experimental subjects underwent caudally based RPSFs using the modified McFarlane technique. Subjects received either topical anti-ischemic drug therapy (nifedipine; n = 6) or inert carrier ointment (placebo; n = 6). Treatment was initiated immediately following flap closure and continued every 6 hours for 5 days. At the end of the treatment period, the animals were killed and the concentration of ET-1 was determined using enzyme-linked immunosorbent assay. Representative tissues from nifedipine- and placebo-treated skin flaps were also analyzed for ET-1 using immunohistochemical stains.
RESULTS: The ET-1 levels in the distal (necrotic) flap segments were increased by 4.53 pg/mL over baseline (nonnecrotic) flaps in the placebo-treated animals and decreased by 4.70 pg/mL below baseline in the nifedipine-treated group (P =.03).
CONCLUSIONS: The correlation between tissue levels of ET-1 and the severity of tissue necrosis suggests that ET-1 may play a pivotal role in ischemic injury of RPSFs. Moreover, treatment with topical nifedipine may antagonize the vasoconstrictive effects of ET-1. Although immunohistochemical analysis revealed ET-1 staining within the flap microvasculature, no quantitative differences were detected between the nifedipine- and placebo-treated flaps. Further studies are needed to define the role of ET-1 in RPSF necrosis.
Authors:
Steven Ross Mobley; Marilyn K Glassberg; Anne Luebke; Chad A Perlyn; Richard E Davis
Related Documents :
9362405 - Comparative prognostic significance of simultaneous versus independent resolution of st...
22988905 - Neurologic safety event rates in the sentis trial control population.
10512255 - Acute smoking increases st depression in humans during general anesthesia.
6500225 - Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in eff...
10090545 - Systematic review of n-acetylcysteine in cystic fibrosis.
12164745 - Uv-b phototherapy clears psoriasis through local effects.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Archives of facial plastic surgery     Volume:  5     ISSN:  1521-2491     ISO Abbreviation:  Arch Facial Plast Surg     Publication Date:    2003 Jan-Feb
Date Detail:
Created Date:  2003-01-20     Completed Date:  2003-06-06     Revised Date:  2012-09-24    
Medline Journal Info:
Nlm Unique ID:  100883500     Medline TA:  Arch Facial Plast Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  78-82     Citation Subset:  IM    
Affiliation:
Divisions of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology, University of Miami School of Medicine, Miami, FL, USA
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Animals
Endothelin-1 / biosynthesis*
Male
Models, Animal
Necrosis
Nifedipine / administration & dosage,  pharmacology*
Prospective Studies
Random Allocation
Rats
Rats, Sprague-Dawley
Skin / blood supply,  drug effects*,  metabolism*,  pathology
Surgical Flaps / blood supply*,  physiology
Vasodilator Agents / administration & dosage,  pharmacology*
Chemical
Reg. No./Substance:
0/Endothelin-1; 0/Vasodilator Agents; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Testing a device to replace the leech for treating venous congestion.
Next Document:  The effect of tension on patency of rat femoral artery anastomoses.